Treatment of idiopathic myelofibrosis [1]

Annals of Hematology

Volumn 79, Issue 11, 2000, Pages 646-647

  Matsukawa, Y ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; METHYLPREDNISOLONE;

ANEMIA; HUMAN; LETTER; MYELOFIBROSIS; PANCYTOPENIA; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0033679110     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000220     Document Type: Letter

References (13)

1. Clinical evidence for 1,25-hydroxy-cholecalciferol action in myelofibrosis
2. The role of interferon α in the treatment of idiopathic myelofibrosis
3. Effects of hydrocortisone on function and structure of human skin fibroblasts in culture
4. Myelofibrosis and systemic lupus erythematosus: Reversal of fibrosis with high-dose corticosteroid therapy
5. 3 in control of bone marrow collagen deposition
6. Idiopathic myelofibrosis: A clinical review
7. Successful high-dose methylprednisolone therapy in a patient with primary myelofibrosis
8. Megadose methylprednisolone effect on myelofibrosis and granulocyte-macrophage colony-stimulating factor
9. Annotation. Pathogenesis of idiopathic myelofibrosis: Present status and future direction
10. 3) in the treatment of idiopathic myelofibrosis
11. Dexamethasone decreases the amounts of type I procollagen mRNAs in vivo and in fibroblast cell cultures
12. Effect of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: A comparative retrospective multicentre histological and clinical study